Secondary placing of shares in Q-Med AB (SE) — SEK 128 million Healthcare Secondary placing of shares in Q-Med AB (SE) — SEK 128 million
Rights issue in Karo Bio (SE) — SEK 125 million Healthcare Rights issue in Karo Bio (SE) — SEK 125 million
Secondary placement of shares in Karo Bio (SE) — SEK 96 million Healthcare Secondary placement of shares in Karo Bio (SE) — SEK 96 million
Rights issue in Biotage AB (SE) — SEK 48 million Healthcare Rights issue in Biotage AB (SE) — SEK 48 million
Divestment of Investor’s 14 per cent stake in Global Health Partner AB (SE) Healthcare Divestment of Investor’s 14 per cent stake in Global Health Partner AB (SE)
Divestment of Sweden Post Office properties (SE) — SEK 2.4 billion Real Estate Divestment of Sweden Post Office properties (SE) — SEK 2.4 billion
Acquisition of FIH (DK) by FöreningsSparbanken and other investors (SE) — DKK 6.6 billion FIG Acquisition of FIH (DK) by FöreningsSparbanken and other investors (SE) — DKK 6.6 billion
Acquisition of Carlson Investment Management (SE) by Skandia (SE) — Amount not disclosed. FIG Acquisition of Carlson Investment Management (SE) by Skandia (SE) — Amount not disclosed.
Directed new share issue in Karo Bio (SE) — SEK 202 million Healthcare Directed new share issue in Karo Bio (SE) — SEK 202 million
Acquisition of Medihem (SE) by Carema Vård och Omsorg (SE) and 3i (UK) from Praktikertjänst (SE) — Amount not disclosed. Healthcare Acquisition of Medihem (SE) by Carema Vård och Omsorg (SE) and 3i (UK) from Praktikertjänst (SE) — Amount not disclosed.
Secondary placing of 5 million shares in Global Health Partner AB (SE) — SEK 53 million Healthcare Secondary placing of 5 million shares in Global Health Partner AB (SE) — SEK 53 million